The UK's Royal Society presented a report (Stem cell research and therapeutic cloning) to members of parliament on 7 November, backing continued research into the use of cloned embryonic stem cells to treat serious injuries and degenerative diseases. The technique, referred to as 'therapeutic cloning', would involve adding the nucleus of a patient's cell to an enucleated egg, and allowing development up to the embryonic stage. The resultant stem cells could then be tailored to treat the relevant disease or injury.

The research has already been approved by an expert group chaired by the Chief Medical Officer, and the UK government is now expected to offer members of parliament a free vote on the issue. Opposition from 'pro-life' groups is to be expected; some have argued that research has shown that adult cells could instead be 'reprogrammed' to behave like embryonic stem cells. The Royal Society report, however,...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?